World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
68
Citations
17007
World Ranking
7772
National Ranking
570

Overview

Martin Müller is affiliated with the German Cancer Research Center in Germany. Their research spans multiple disciplines including Medicine, Immunology and Microbiology, as well as Biochemistry, Genetics and Molecular Biology. This interdisciplinary approach reflects a broad engagement with both clinical and molecular aspects of disease and immune response.

The subfields of study prominently featured in their work include Epidemiology, Immunology, Molecular Biology, Genetics, and Animal Science and Zoology. These areas provide a foundation for their research into infectious diseases, immune mechanisms, and genetic factors influencing health outcomes.

The scientist's primary research topics encompass Cervical Cancer and HPV Research, Immunotherapy and Immune Responses, Hepatitis B Virus Studies, the role of interferon in immune responses, Virus-based gene therapy research, Herpesvirus Infections and Treatments, and Animal Virus Infections Studies. These focal points suggest a strong emphasis on viral pathogens and immune modulation.

Frequent publication venues for Martin Müller include Frontiers in Immunology, npj Vaccines, Vaccine, bioRxiv (Cold Spring Harbor Laboratory), and Cell Reports. These journals underscore the scientist's active contribution to immunology and vaccine research communities.

Martin Müller's frequent co-authors are:

  • Filipe Colaço Mariz
  • Peter Sehr
  • Tim Waterboer
  • Simone Ottonello
  • Xueer Zhao

Their recent papers include:

  • Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination (2022), published in Vaccine
  • Pre-arrayed Pan-AAV Peptide Display Libraries for Rapid Single-Round Screening (2020), published in Molecular Therapy
  • Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials (2021), published in The Lancet Infectious Diseases
  • Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines (2020), published in npj Vaccines
  • Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines (2020), published in Vaccine

Best Publications

  • Carrageenan Is a Potent Inhibitor of Papillomavirus Infection

    Christopher B Buck;Cynthia D Thompson;Jeffrey N Roberts;Martin Müller

  • Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

    Susanne Saussele;Johan Richter;Joelle Guilhot;Franz X Gruber

  • Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial

    Jorge E. Cortes;Dong Wook Kim;Javier Pinilla-Ibarz;Philipp D. le Coutre

  • Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

    Simona Soverini;Andreas Hochhaus;Franck E. Nicolini;Franz Gruber

  • Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

    Rüdiger Hehlmann;Michael Lauseker;Susanne Jung-Munkwitz;Armin Leitner

  • Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

    Timothy Hughes;Giuseppe Saglio;Susan Branford;Simona Soverini

  • Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV

    Rüdiger Hehlmann;Martin C. Müller;Michael Lauseker;Benjamin Hanfstein

  • Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

    Alice Fabarius;Armin Leitner;Andreas Hochhaus;Martin C. Müller

  • Chimeric Papillomavirus-like Particles

    Martin Müller;Jian Zhou;Tracey D Reed;Claudia Rittmüller

  • Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

    Rengaswamy Sankaranarayanan;Priya Ramesh Prabhu;Michael Pawlita;Tarik Gheit

  • Sustained molecular response with interferon alfa maintenance after induction therapy with imatinib plus interferon alfa in patients with chronic myeloid leukemia.

    Andreas Burchert;Martin C. Müller;Philippe Kostrewa;Philipp Erben

  • Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques

    Christiane Stahl-Hennig;Martin Eisenblätter;Edith Jasny;Tamara Rzehak

  • Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection.

    Klaus Schäfer;Martin Müller;Stefan Faath;Annette Henn

  • HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase

    Peter Sehr;Martin Müller;Reinhard Höpfl;Andreas Widschwendter

  • Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV

    Susanne Saußele;Marie-Paloma Krauß;Rüdiger Hehlmann;Michael Lauseker

  • The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis

    Philipp Erben;Juliana Schwaab;Georgia Metzgeroth;Hans-Peter Horny

  • Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia

    Andreas Burchert;Stefan Wölfl;Manuel Schmidt;Cornelia Brendel

  • Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib

    Thomas Ernst;Philipp Erben;Martin C Müller;Peter Paschka

  • Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells.

    Elisabeth Bolton-Gillespie;Mirle Schemionek;Hans-Ulrich Klein;Sylwia Flis

  • Next generation prophylactic human papillomavirus vaccines

    John T Schiller;Martin Müller

Frequent Co-Authors

Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Lutz Gissmann
Lutz Gissmann German Cancer Research Center
Timothy P. Hughes
Timothy P. Hughes South Australian Health and Medical Research Institute
Jorge E. Cortes
Jorge E. Cortes Augusta University
Neil P. Shah
Neil P. Shah University of California, San Francisco
Moshe Talpaz
Moshe Talpaz University of Michigan–Ann Arbor
Simone Ottonello
Simone Ottonello University of Parma
Francois Guilhot
Francois Guilhot Grenoble Alpes University
Michele Baccarani
Michele Baccarani University of Bologna
Victor M. Rivera
Victor M. Rivera Takeda (Japan)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees offers flexible pathways for students interested in Biology, Biochemistry, and related fields. A popular option is pursuing online biology programs, which let you study remotely and at your own pace while preparing for careers in research, healthcare, or education.

For those looking to enter allied health professions quickly, programs such as ma to lpn bridge programs online can help medical assistants transition efficiently to become licensed practical nurses. Similarly, earning an online asn program opens opportunities in nursing, offering foundational knowledge and hands-on skills required in clinical settings.

Interest in health and wellness careers also continues to rise. An online degree in nutrition prepares graduates for roles in dietetics, public health, and research, blending scientific understanding with practical application.

Online learning makes it easier than ever to start or advance your career in science and health-related fields, fitting study around your life, and enabling you to gain accredited qualifications from wherever you are.

Best Scientists Citing Martin Müller

Trending Scientists

Recently Published Articles